⚠ Evidence note: Most trends in this area rest on anecdote and mechanism; where real evidence exists it is usually for narrower claims than the trend makes.
Plasma Exchange and Young Blood
Current understanding
From parabiosis experiments to clinics selling apheresis — watch the translation gap.
Evidence log
- 2026-11-12 — Youthful circulation reshapes age-associated DNA methylation across blood and liver.: Mouse heterochronic parabiosis study [animal-model]: exposure to youthful shared circulation reversed age-associated DNA methylation patterns in blood and liver, with changes persisting two months after separation; these molecular findings do not establish human rejuvenation or the efficacy or safety of plasma exchange or young-plasma transfusions. [animal-model] (novelty: 3)
- 2026-09-23 — Human Albumin Combined With Plasma Exchange for Frailty Intervention: Planned exploratory RCT protocol (n=34) proposing therapeutic plasma exchange with human albumin ± IVIg for frailty; no efficacy readout, trial not yet initiated. [expert-opinion] (novelty: 3)
- 2026-08-12 — Youth-associated protein TIMP2 regulates microglial state and function in healthy and aged mice.: Mouse study: TIMP2, a youth-associated plasma factor previously linked to hippocampal/ECM effects, bidirectionally regulates microglial activation, lysosomal/phagocytic function, and extracellular inflammatory stress — knockout worsens aged-microglia phenotypes, TIMP2 administration to aged mice partially reverses them; no human readout. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Youthful circulation reshapes age-associated DNA methylation across blood and liver.
12-nov-2026
novelty 3
per-area 3
strengthens
Age: a modifiable risk factor for cardiovascular disease?
02-nov-2026
novelty 2
per-area 1
mentions
Correction to “Impaired Cytokine Secretion Contributes to Age‐Dependent Immune Dysfunction in SARS Coronavirus Response and Is Restored by Young CD11b‐Positive Cell Transfer”
26-sep-2026
novelty 1
per-area 1
mentions
Human Albumin Combined With Plasma Exchange for Frailty Intervention
23-sep-2026
novelty 3
per-area 3
strengthens
Engineered Exosomes as a Treatment for Alzheimer's Disease
07-sep-2026
novelty 2
per-area 1
mentions
A Mechanism-Based Framework for Anti-Aging Strategies: From Metabolic Regulation to Senotherapy and Stem Cell-Based Interventions.
01-sep-2026
novelty 2
per-area 2
mentions
Youth-associated protein TIMP2 regulates microglial state and function in healthy and aged mice.
12-aug-2026
novelty 3
per-area 3
strengthens
The circulating senosome: Blood as the therapeutic interface of aging.
19-jul-2026
novelty 3
per-area 2
mentions
Targeting innovative therapeutic approaches to the hallmarks of aging to combat Alzheimer's disease.
30-dec-2025
novelty 2
per-area 3
strengthens